Aspire-Lakewood Holdings, Inc.
- Last sale
- Nov 12, 2026 · -1.69%
- Market cap
- $12.24M
- 1.4M shares
- Filings
- 230
Q2 2026
—Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
—
—
—Q2 2026N/M FY25 yoy
Q2 2026+27,532.9% FY25 yoy
- $12.24M
- —
- 1974.3×
- 1.0×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $6,202 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $13.78M | $13.78M | — | 48.90M sh | — | — |
| FY2023 | — | $284.92M | $284.92M | — | — | — | — |
Segments
Geography
LineFY2025ShareChange
UNITED STATES$6.15K99%—
CANADA$30.000.5%—
UNITED KINGDOM$19.000.3%—
Total$6.20K
Pharmaceutical preparations
Aspire-Lakewood Holdings, Inc. is the 259th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
IBOImpact Biomedical Inc.$32.0K—36,993.8%$41.5MTLPHTalphera, Inc.$28.0K—51,035.7%$53.5MJUNSJupiter Neurosciences, Inc.$21.8K—39,662.8%$1.8MSKVISkinvisible, Inc.$20.0K0.0%5,320.2%$1.1MBDPTBioadaptives, Inc.$18.3K44.3%8,523.4%$240.2KPRFXPRF Technologies Ltd.$17.0K—29,541.2%$606.3KGNLXGenelux Corp$8.0K0.0%401,812.5%$86.2M
ASBPAspire-Lakewood Holdings, Inc. (this company)$6.2K—394,725.1%$12.2M
TCRTAlaunos Therapeutics, Inc.$5.0K50.0%83,520.0%$4.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Aspire-Lakewood Holdings, Inc. · CIK 1847345 · Engraved from SEC EDGAR